0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover906.50%IV-700.00%PremiumJan 17, 2025Expiry Date8.75Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8848Delta0.1360Gamma0.14Leverage Ratio-0.0207Theta-0.0010Rho-0.13Eff Leverage0.0003Vega
Rani Therapeutics Stock Discussion
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
No comment yet